Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pentagamavunon-0

Known as: PGV-0 compound 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
ABSTRACT Objectives: This experiment aims to investigate the apoptosis effect of curcumin and its analogs pentagamavunon-0 (PGV-0… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
A salt compound of a curcumin analogue, potassium pentagamavunon-0 (K PGV-0) has been synthesized to improve solubility of… Expand
  • figure 1
  • figure 2
  • figure 5
  • figure 3
  • figure 6
2016
2016
Abstract: Transdermal delivery system is one of the delivery system for Pentagamavunon-0 (PGV-0) to  avoid the high intensity of… Expand
2015
2015
Abstract The research aims was to determine the cytotoxic effects and the highest safe concentration of curcumin and PGV-0… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
2013
2013
OBJECTIVE To investigate the hepatoprotective and antioxidant activity of pentagamavunon-0(PGV-0) against CCl4-induced hepatic… Expand
  • table 1
  • table 2
  • table 3
2006
2006
Breast cancer is the most common cancer occurring in women. Pentagamavunon-0 (2,5-bis-(4’-hidroxy-3’-methoksy)-benzilidine… Expand
2005
2005
The compound 2,5-bis-(4’-hydroxy-3’-methoxybenzilidin) cyclopentanone or Pentagamavunon-0 (PGV-0) as the new anti-inflamatory… Expand
2005
2005
Pentagamavunon-0 (PGV-0) or 2,5-bis-(4-hydroxy-3-methoxy benzyilidin) cyclopentanon is a synthetic compound which has been proved… Expand
2005
2005
PGV-0 is a curcumin derivate, a synthetic compound which may be a candidate of a new drug. This substance has a potent… Expand
2004
2004
Inflammation is the response of living tissues to injury. The process affects physiological changes such as erythema, edema… Expand